IDENTIFICATION OF ENDOTHELIN RECEPTOR SUBTYPES IN HUMAN RENAL-CORTEX AND MEDULLA USING SUBTYPE-SELECTIVE LIGANDS

被引:84
作者
NAMBI, P
PULLEN, M
WU, HL
AIYAR, N
OHLSTEIN, EH
EDWARDS, RM
机构
关键词
D O I
10.1210/en.131.3.1081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High affinity and high density endothelin (ET)-binding sites were identified in membranes prepared from human kidney cortex and medulla. Saturation binding experiments performed in membranes prepared from cortex and medulla using [I-125]ET-1 and [I-125]ET-3 revealed that the proportion of [I-125]ET-3-binding sites was 30-35% less than that of [I-125]ET-1-binding sites. The apparent dissociation constants and maximum binding for [I-125]ET-1 and [I-125]ET-3 to membranes from cortex were 91 +/- 5 pm and 165 +/- 10 fmol/mg protein, and 117 +/- 9 pM and 110 +/- 7 fmol/mg protein, respectively, whereas in medulla they were 139 +/- 10 pm and 360 +/- 11 fmol/mg protein, and 142 +/- 11 pm and 245 +/- 15 fmol/mg protein, respectively. In the presence of 10 nm sarafotoxin-6c, which is selective for ET(B) receptors, [I-125]ET-1 binding was decreased by 65-70%, whereas [I-125]ET-3 binding was totally abolished, suggesting that 65-70% of [I-125]ET-1 binding and 100% of [I-125]ET-3 binding was to ET(B) receptors. This was further confirmed by the use of a cyclic pentapeptide [cyclo(D-Trp,D-Asp,L-Pro,D-Val,L-Leu)] (BQ123), which is selective for ETA receptors. In the presence of 1-mu-M BQ123, [I-125]ET-1 binding was decreased by 25-30%, whereas [I-125]ET-3 binding was unaffected, confirming that 30-35% of ET receptors belong to the ET(A) subtypes, and that [I-125]ET-1 bound to both ET(A) and ET(B) receptors with the same high affinity, but [I-125]ET-3 bound only to ET(B) receptors with high affinity. These results suggest that human kidney cortex and medulla contain ET(A) and ET(B) receptors in a ratio of 30:70, and that sarafotoxin-6c and BQ123 are valuable tools in identifying the subtype of ET receptors in various tissues.
引用
收藏
页码:1081 / 1086
页数:6
相关论文
共 44 条
[1]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[2]   ENDOTHELIN AND CA++ AGONIST BAY-K-8644 - DIFFERENT VASOCONSTRICTIVE PROPERTIES [J].
AUGUET, M ;
DELAFLOTTE, S ;
CHABRIER, PE ;
PIROTZKY, E ;
CLOSTRE, F ;
BRAQUET, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :186-192
[3]   MESANGIAL CELL, GLOMERULAR AND RENAL VASCULAR-RESPONSES TO ENDOTHELIN IN THE RAT-KIDNEY - ELUCIDATION OF SIGNAL TRANSDUCTION PATHWAYS [J].
BADR, KF ;
MURRAY, JJ ;
BREYER, MD ;
TAKAHASHI, K ;
INAGAMI, T ;
HARRIS, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (01) :336-342
[4]   HIGH AND LOW AFFINITY BINDING-SITES FOR ENDOTHELIN ON CULTURED RAT GLOMERULAR MESANGIAL CELLS [J].
BADR, KF ;
MUNGER, KA ;
SUGIURA, M ;
SNAJDAR, RM ;
SCHWARTZBERG, M ;
INAGAMI, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :776-781
[5]   TISSUE-SPECIFICITY OF ENDOTHELIN BINDING-SITES [J].
BOLGER, GT ;
LIARD, F ;
KROGSRUD, R ;
THIBEAULT, D ;
JARAMILLO, J .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (03) :367-375
[6]   SPECIFIC BINDING OF ENDOTHELIN ON HUMAN VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE [J].
CLOZEL, M ;
FISCHLI, W ;
GUILLY, C .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1758-1761
[7]   ENDOTHELIN BINDING TO CULTURED CALF ADRENAL ZONA GLOMERULOSA CELLS AND STIMULATION OF ALDOSTERONE SECRETION [J].
COZZA, EN ;
GOMEZSANCHEZ, CE ;
FOECKING, MF ;
CHIOU, S .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) :1032-1035
[8]   BINDING-SITES FOR I-125-LABELED ENDOTHELIN-1 IN THE KIDNEYS - DIFFERENTIAL DISTRIBUTION IN RAT, PIG AND MAN DEMONSTRATED BY USING QUANTITATIVE AUTORADIOGRAPHY [J].
DAVENPORT, AP ;
NUNEZ, DJ ;
BROWN, MJ .
CLINICAL SCIENCE, 1989, 77 (02) :129-&
[9]  
DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
[10]   ENDOTHELIUM-DEPENDENT VASCULAR ACTIVITIES OF ENDOTHELIN-LIKE PEPTIDES IN THE ISOLATED SUPERIOR MESENTERIC ARTERIAL BED OF THE RAT [J].
DOUGLAS, SA ;
HILEY, CR .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (01) :81-88